Introduction
Syncope and collapse (syncope/collapse) account for approximately 1% of European Emergency Departments (EDs) case load.
1,2 While many episodes of syncope/collapse prove benign; injury, accidents, reduced quality of life, and rarely, death may occur, with cardiac syncope raising greatest concern. 3, 4 Thus, understanding the basis of syncope/collapse, and developing effective prevention is important. In the United Kingdom (UK) and Germany, there are two sets of practice guidelines covering diagnostic evaluation of syncope/collapse patients. 4, 5 Two references are given for the European Society of Cardiology (ESC) the 2009 version 4 that were in use during the present study, recently updated 2018. 5 The National Institute for Health and Clinical Excellence (NICE) guidelines are predominantly followed in UK, 6 while ESC guidelines are followed in Germany. 4, 5 Both guidelines offer diagnostic strategies for determining syncope/collapse aetiology. Briefly, if a cause is not identified by initial medical history, physical examination, and 12-lead electrocardiogram (ECG), 4 the next step is usually short-or longer-term diagnostic ambulatory electrocardiogram (AECG) monitoring.
Appropriate choice among currently available AECG monitoring technologies is important. Recommendations for selection of appropriate AECG technology are provided in guidelines, [4] [5] [6] recent publications, [7] [8] [9] and the Syncope Unit Project. 10, 11 Specifically, both NICE and ESC guidelines documents recommend use of Holter monitors when event recurrence rates are very frequent (daily), wearable event monitors for less frequent episodes (weekly-monthly), and insertable cardiac monitors (ICMs) when symptoms occur infrequently. [4] [5] [6] The principal objective of the survey reported here was to ascertain the 'real world' manner in which available diagnostic AECG monitoring technologies are selected by EDs and cardiologists practising in UK and Germany. The goal was to determine whether clinical practice corresponds to current guidelines and where they diverge.
Methods
This report comprises findings obtained from a survey undertaken JulyDecember 2015 of EDs and cardiologists in UK and Germany. The survey was conducted by an independent polling agency (ZS Associates, Evanston, IL, USA). Care was taken to avoid identification of specific device manufacturers. The study was sponsored by Medtronic Inc. Minneapolis, MN, USA but sponsor personnel did not participate in recording or interpreting the observations. An honorarium of US$100 was paid to respondents.
Physicians, selected from hospital staff lists, who indicated interest in participating in the survey underwent qualification prior to acceptance and completed a quantitative survey instrument on-line; respondents were deemed qualified if they fulfilled the following criteria:
(1) Currently 2-30 years post-training (2) Board certified in their specialty (3) >75% of their time spent caring for patients (4) Emergency Departments and non-implanting cardiologists (NICs):
reported caring for >5 syncope/collapse patients/month of whom >50% were suspected to be of cardiac origin. Respondents were asked to exclude accidental falls and epileptic seizures. (5) Implanting cardiologists (IC): reported caring for >2 syncope/collapse cases/month and implanting >5 ICMs in past year. Accidental falls and epileptic seizures were again excluded. (6) Were aware of the variety of wearable ambulatory diagnostic ECG technologies available and had knowledge of ICMs.
Data analysis
The statistical plan required a sample size of 30 qualified individuals for each physician subgroup, which allowed sufficient qualified respondents assuming that test parameters in the larger population of physicians in that sub-specialty are normally distributed. Hypothesis testing was conducted using z-test and Student's t-test for proportions and averages, respectively to ensure that samples compared belonged with equivalent populations. Statistical significance was set at 95% confidence level.
Results
Findings summarized here comprise responses from 177 physicians (73 ED and 104 cardiology) who met qualification criteria. The years of practice experience were, for UK responders, 14.4 for EDs, 12.9 for NICs, and 24.5 for ICs. All UK EDs and 85% of German EDs worked in public hospitals. For NICs, UK and Germany public hospital percentages were 93% and 58%, respectively, whereas for ICs the public hospital percentages were 98% and 82%, respectively.
Non-implanting cardiologists and ICs were questioned regarding syncope/collapse diagnoses, that they encountered, as a percentage of all patients. There were no significant differences between UK and German cardiologists, and the data are combined ( Table 1 , percentage data are provided as mean ± standard deviation, 25-75th quartile).
Factors driving monitor technology choice
Primary factors driving selection of monitoring technology for a given TLOC (transient loss of consciousness) patient was evaluated ( Figure 1 , Table 2 ). Both EDs and cardiologists in UK and Germany indicated that the most important driver was their impression of obtaining a useful diagnostic yield. Second in importance was frequency with which TLOC recurrence was expected (Figures 2 and 3) .
In terms of device choice, both UK and German physicians tended to follow guidelines appropriate to their regions (NICE in UK 6 ; ESC in Germany 4 ), but in each case there were important divergences, these were particularly notable among EDs who may be expected to be less familiar with guidelines than are cardiologists. The survey revealed that most UK EDs (80%) follow NICE guidelines for Holter use for daily symptoms, 6 but diverged from NICE for
Holter recordings if expected frequency of events was 2-3/week, when 73% preferred event monitors or ICMs (P < 0.05). However, approximately 30% of these same physicians indicated, in contradistinction to NICE recommendations for ICM, that they would select wearable event monitors or Holter even for anticipated episode recurrences of <6 monthly ( Figure 2 ). Among German EDs, 69% follow ESC guidelines for Holter with daily symptoms (P < 0.05 vs. Event/ICM); the remainder prefer longer-term monitors ( Figure 3) . However, only 46-54% would follow ESC guidelines for ICM use when event frequency is <6 monthly. About one-third of UK EDs would continue with Holters or wearable event recorders, compared with German physicians ranging from 15% to 25% ( Figure 3 ). UK cardiologists (94%) follow NICE Holter recommendations for daily symptoms, but only 43% follow NICE recommendations for What's new?
• The following of Syncope Guidelines for selection of diagnostic ambulatory electrocardiogram devices is presently unclear.
• Emergency physicians' and cardiologists' syncope practice, in UK and Germany, has been surveyed.
• Most UK and German practitioners follow local or European Guidelines but a substantial minority diverges from them in use of insertable cardiac monitors and selection of a second monitoring technology when the first yields no diagnosis.
Holter recordings for event frequencies of 2-3/week. Most UK cardiologists (75-83%) follow NICE guidelines for ICM use when symptoms are expected <6 monthly (Figure 4) .
German cardiologists also largely follow ESC guidelines for Holter use or daily symptoms (90%) ( Figure 5 ). In addition, 76% follow recommendations for Holters when expecting event rates of 2-3/week. Further, German cardiologists closely follow ESC guidelines for use of ambulatory monitors in patients with low frequency symptoms, with 76-82% recommending ICMs.
Repeat monitoring
Often, initial monitoring may not provide a definitive diagnosis and physicians may decide to continue AECG monitoring for an additional period of time ('follow-up monitoring'). In assessment of 'follow-up' monitoring preferences, responses were divided into EDs, cardiologists practising primarily in hospitals, and cardiologists primarily office-based ( Figure 6 ).
Findings reveal that many physicians persist with the same methodology. In general, although differences were not statistically significant, Ambulatory ECG for syncope the survey suggested that German EDs and cardiologists, tended to repeat the same monitoring more so than did UK physicians ( Figure  6 ). Factors driving repeated use of the same external monitoring tool are summarized in Table 2 . The most important drivers were ease of use (UK 73%, Germany 60%) and non-invasive nature of the monitor (UK 64%, Germany 60%) ( Table 2) .
Discussion Main findings
This survey examined the current 'real world' application of both wearable ambulatory ECG recorders and ICMs for diagnosis of patients presenting with 'syncope/collapse' by UK and German EDs ), we aimed to ascertain the degree to which clinical practice conformed to appropriate regional guidelines.
There were four main findings. First, both sets of guidelines emphasize that choice of monitor type should be based on expected time to symptom recurrence. The survey indicated that most EDs and cardiologists conform to guidelines but, important divergences were identified. The vast majority of physicians appropriately use Holter monitors as recommended for daily symptom recurrences. However, the majority departs from the same Holter recommendations, preferring longer-term event recorders, when expected event recurrence is 2-3/week. Conversely, while most physicians adhere to ICM guidelines for very infrequent events (<6 monthly), a substantial minority (30%) indicated preference for short-/intermediate-term monitoring over ICMs Second, UK and German cardiologists appeared to follow their regional practice guidelines more closely than did EDs. Perhaps, due to the fact that EDs face such a broad range of problems, they are less likely to be as familiar with primarily cardiology-based AECG guidelines. Third, when repeat AECG monitoring was needed in patients in whom initial AECG recordings were unrevealing, a substantial proportion of physicians tended to persist with the same technology. Finally, the relative frequency of syncope/ collapse diagnoses, as reported by the cardiologists surveyed, was similar in both UK and Germany. Consequently, any variance regarding AECG monitoring strategies among cardiologists cannot be attributed to patient population differences.
Choosing among ambulatory electrocardiogram monitor technologies
Ambulatory electrocardiogram monitors, both wearable and insertable, are now widely used by physicians throughout the world for evaluation of cause of many troublesome symptoms likely due to cardiac arrhythmia, including palpitations, lightheadedness, collapse, and intolerance of cutaneous ECG electrodes, cumbersome nature of devices, or desire to assess treatment effect after diagnosis, may prompt ICM choice at an early stage. Current generation ICMs offer recording of 3 years, very low risk of skin irritation/infection and almost imperceptible surgical scars.
Limitations
The interpretation of findings in this survey is subject to several limitations. First, although meeting the pre-determined statistical plan, the number of respondents was small, Second, responses from participants were based on recollection of recent practice which inevitably reduces data quality compared with prospective studies. Third, in most European hospitals it is not customary for EDs to initiate AECG monitoring. However, while UK and German EDs may be prescribing monitoring more often than expected, it is likely that follow-up is by cardiologists, and consequently 
Conclusion
In conclusion, in the evaluation of syncope/collapse, most UK and German Emergency Department and Cardiology clinicians appear to employ ambulatory ECG technology appropriately based on regional guidelines (NICE in UK, ESC in Germany). Nonetheless, in a substantial minority there remain divergences between choice of monitoring technology and guideline-based recommendations.
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